| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash used in financing activities | -1,248,400 | -292,400 |
| Net (decrease) increase in cash and cash equivalents | -357,100 | -104,100 |
| Cash and cash equivalents at beginning of period | 1,697,200 | - |
| Cash and cash equivalents at end of period | 1,340,100 | - |
UNITED THERAPEUTICS Corp (UTHR)
UNITED THERAPEUTICS Corp (UTHR)